It has to be mentioned also that IL-17R deficiency increased CD8 T cells and reduced MDSCs tumor infiltration [82], and systemic administration of IL-17 promoted tumor growth, enhanced MDSCs and reduced CD8 T cells tumor infiltration [82]. The gene discussed is IL17A; the disease is neoplasm.